CJC-1295 with DAC is a long-acting peptide studied for its ability to stimulate growth hormone release through GHRH receptor signalling. Research interest focuses on ageing, recovery, body composition, and endocrine rhythm stability. In Australia, CJC-1295 with DAC is commonly researched within longevity and metabolic science discussions. This article explains how it works and why it is studied.
What Is CJC-1295 With DAC?
CJC-1295 is a synthetic analogue of growth hormone-releasing hormone (GHRH). The addition of DAC (Drug Affinity Complex) allows the peptide to bind to albumin, significantly extending its half-life in circulation.
This modification distinguishes CJC-1295 with DAC from shorter-acting GHRH peptides.
Why It Is Researched
CJC-1295 with DAC is studied for:
- Sustained growth hormone pulsatility
- Age-related decline in GH signalling
- Recovery and tissue maintenance research
- Metabolic regulation pathways
Growth hormone plays a key role in repair and regeneration, making this peptide relevant to longevity research.
Reported Research Observations
In controlled studies, CJC-1295 with DAC has been associated with:
- Increased GH and IGF-1 signalling
- Preservation of natural GH pulse patterns
- Improved recovery markers in models
These findings are experimental and not therapeutic claims.
Mechanism of Action
CJC-1295 with DAC works by:
- Binding to GHRH receptors in the pituitary
- Stimulating endogenous GH release
- Extending activity via albumin binding
Importantly, it does not directly introduce growth hormone.
Storage and Stability
Long-acting peptides require:
- Proper cold storage
- Protection from agitation
- Careful reconstitution to preserve DAC integrity
Australian shipping distance often increases the importance of proper logistics.
Research-Only Disclaimer
CJC-1295 with DAC is supplied strictly for research use and is not approved by the TGA.
Written by the Tides Lab Research Team
The Tides Lab Research Team publishes educational guides on peptide signalling pathways, metabolic peptides and laboratory research compounds.
0 comments